Quarterly report pursuant to Section 13 or 15(d)

The Company and Basis of Presentation (Tables)

v3.22.1
The Company and Basis of Presentation (Tables)
3 Months Ended
Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Revised Financial Statements The effect of this revision on certain line items within our condensed consolidated balance sheets and condensed consolidated statements of operations and comprehensive income (loss) are set forth below:
As of or for the three months ended
March 31, 2021
Previously reported Adjustments As revised
Warrant liability $ 2,499  $ 1,944  $ 4,443 
Accumulated deficit $ (158,166) $ (1,944) $ (160,110)
Loss on change in fair value of warrant liability $ (885) $ (1,944) $ (2,829)
Net loss $ (12,363) $ (1,944) $ (14,307)
Net loss per common share, basic and diluted $ (0.19) $ (0.03) $ (0.22)